Clinical TrialsSearch results
Number of results: 702
Recruiting
- Phase II study of prophylactic oral administration of diltiazem for atrial fibrillation after lung resection
- atrial fibrillation after lung resection
- Department of Surgical Oncology, Hokkaido University Graduate School of Medicine
- 2009-02-06
Recruiting
- Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.
- Gastric cancer
- Tokushima-Hokkaido cancer therapy clinical trial group
- 2009-10-01
Recruiting
- Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
- colorectal cancer
- Translational Research Informatics Center(TRI)
- 2009-08-07
Recruiting
- Phase I/II study of rapcabtagene autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL
- DLBCL, ALL, CLL
- Yamauchi Kyosuke
- 2022-01-31
Recruiting
- Phase 3 Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
- Locally advanced or metastatic non-squamous non-small cell lung cancer
- Imanishi Naoki
- 2023-06-03
Recruiting
- Phase 3 Study of Trastuzumab Deruxtecan as First-line Treatment of Unresectable, Locally Advanced, or Metastatic NSCLC Harboring HER2 Exon 19 or 20 Mutations (DESTINY-Lung04)
- NSCLC Harboring HER2 Exon 19 or 20 Mutations
- Inoguchi Akihiro
- 2021-12-23
Recruiting
- Perioperative serum SIRT6 and flailty
- Frailty
- Tachibana Shunsuke
- 2024-06-18
Recruiting
- Oropharyngeal leak pressure of supraglottic airway devicd at head rotation
- Diseases needed operation under general anesthesia
- Chaki Tomohiro
- 2021-10-18
Recruiting
- optimization of MSC production
- spinal cord injury
- Sasaki Masanori Masanori
- 2023-02-28
Recruiting
- ONO-4685-05:A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
- Relapsed or refractory T-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
- Osawa Masahiro
- 2023-11-19